Navigation Links
No small feat: First ever gene therapy success for muscular dystrophy achieved

Researchers from the University of Pittsburgh report the first study to achieve success with gene therapy for the treatment of congenital muscular dystrophy (CMD) in mice, demonstrating that the formidable scientific challenges that have cast doubt on gene therapy ever being feasible for children with muscular dystrophy can be overcome. Moreover, their results, published in this week's online edition of the Proceedings of the National Academy of Sciences (PNAS), indicate that a single treatment can have expansive reach to muscles throughout the body and significantly increase survival.

CMD is a group of some 20 inherited muscular dystrophies characterized by progressive and severe muscle wasting and weakness first noticed soon after birth. No effective treatments exist and children usually die quite young.

Despite gene therapy being among the most vigorously studied approaches for muscular dystrophy, it has been beset with uniquely difficult hurdles. The genes to replace those that are defective in CMD are larger than most, so it has not been possible to apply the same methods successfully used for delivering other types of genes. And because CMD affects all muscles, an organ that accounts for 40 percent of body weight, gene therapy can only have real therapeutic benefit if it is able to reverse genetic defects in every cell of the body's 600 muscle groups.

By using a miniature gene, similar in function to the one defective in CMD, and applying a newly developed method for "systemic" gene delivery, the Pitt researchers have shown that gene therapy for muscular dystrophy is both feasible and effective in a mouse model of especially profound disease. Using this approach, the team, led by Xiao Xiao, Ph.D., associate professor of orthopaedic surgery and molecular genetics and biochemistry at the University of Pittsburgh School of Medicine, report that treated mice had physiological improvements in the muscles of the heart, diaphragm, abdomen and l
'"/>

Source:University of Pittsburgh Medical Center


Page: 1 2 3

Related biology news :

1. Stopping smallpox in its tracks: A new anti-viral approach
2. New World founders small in number
3. Secret of smallpoxs success may lead to bioterror cure
4. Circulating stem cells play small role in lung repair
5. LIAI scientists make major finding on potential smallpox treatment
6. Researchers develop new testing methods for potential monkeypox or smallpox outbreak
7. Solexa and collaborating scientists illuminate the small RNA component of the transcriptome
8. Delaware scientists make significant advance in study of small RNAs
9. Scientists learn to predict protein-stabilizing ability of small molecules
10. One small step means giant leap for spinal cord research
11. New study of the worlds smallest elephant
Post Your Comments:
(Date:12/17/2014)... , Dec. 15, 2014 The Defense Logistics ... to detect and prevent counterfeit microcircuits from entering into ... performing an in-house microcircuit anti-counterfeit initiative dubbed DNA marking. ... while increasing their reliability throughout the supply chain. The ...
(Date:12/17/2014)... Dec. 16, 2014 Research and Markets ( ... "Global Chemical Sensor Market 2015-2019" report to their ... One major trend upcoming in this market is ... Chemical sensors help in recording of patient data for ...
(Date:12/11/2014)... Research and Markets , ... announced the addition of the "Biometrics Market in ... One major trend emerging in this market ... it is important to upgrade biometric solutions to the ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... FASEB MARC (Maximizing Access to Research Careers) Program has announced ... 2013) meeting in Boston, MA from April 20-24, 2013. These ... doctorates and scientists from underrepresented groups into the mainstream of ... young scientists at EB 2013. MARC TRAVEL AWARDS ...
... little things can add up to a lot. In ... small dams, streams and pollution by Steve Powers, a ... Change Initiative (ECI). "Small dams, reservoirs and ponds ... water resources," Powers said. "This is especially relevant in ...
... in French . , The Journal of ... electronic-only publication that is now accepting papers; the inaugural issue is ... with Unmanned Systems Canada (USC-STC) and with support from the Kenneth ... the NRC Research Press journal roster. This new title aims ...
Cached Biology News:MARC travel awards announced for EB 2013 2MARC travel awards announced for EB 2013 3MARC travel awards announced for EB 2013 4MARC travel awards announced for EB 2013 5Notre Dame researcher is studying role small dams play in pollution control 2NRC Research Press adds a new title to collection of scientific and technical journals 2
(Date:1/23/2015)... BOULDER, Colo. , Jan. 23, 2015  Array BioPharma ... it has reached a definitive agreement with Novartis Pharma ... BRAF inhibitor currently in Phase 3 development.  This agreement is ... and GlaxoSmithKline PLC (GSK) on April 22, 2014, which are ...
(Date:1/22/2015)...  Transwestern | RBJ today announces the firm brokered a long-term ... a leading biopharmaceutical company, at Two Ledgemont Center in ... Richards , president, and Brian Cohen , senior vice ... building at 95 Hayden Ave. Photo - ...
(Date:1/22/2015)... January 22, 2015 The laboratory information ... has witnessed a number of technological advancements due to ... requirements, growing need to integrate healthcare systems, and increasing ... challenges in system integration. Key players in the market ...
(Date:1/22/2015)... zFlo Motion , a US leader in ... product from a new partner. STT-Systems has developed ... 15 years, with offerings in the optical-motion capture, 3D scanning, ... (inertial measurement unit), iSen, is opening eyes around the world. ...
Breaking Biology Technology:Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 2Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 3Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 4Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 5Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 6Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 7Transwestern | RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 43D Motion Capture Just Got Easy 2
... ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ), today reported ... ISTA reported net revenue of $32.0 million for the ... net revenue for the three months ended September 30, 2008. ... September 30, 2009 is $1.2 million associated with the launch ...
... Nov. 3 Texas State University and Orizon Research ... will permit University Researchers to continue efforts through in ... of ALKA-V6, a compound which has shown remarkable ability ... in laboratory experiments. , The research will evaluate the ...
... scientists today unveiled a method for the industrial-scale processing ... advances in materials science, power distribution and nanoelectronics. The ... tried-and-true processes that chemical firms have used for decades ... the journal Nature Nanotechnology . "Plastics is ...
Cached Biology Technology:ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results 2ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results 3ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results 4ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results 5ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results 6ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results 7ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results 8ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results 9Texas State University Prepares for Phase 2 Research on the Potential New Cancer and HIV Fighting ALKA-V6 Compound 2Texas State University Prepares for Phase 2 Research on the Potential New Cancer and HIV Fighting ALKA-V6 Compound 3Breakthrough in industrial-scale nanotube processing 2Breakthrough in industrial-scale nanotube processing 3Breakthrough in industrial-scale nanotube processing 4
Rat Hepatocytes (RH) (>3,000,000 cells)...
Rat Cardiac Fibroblasts (RCF) (>500,000 cells)...
... is a concentrated formulation of a rinsing ... action technology, as well as for manual ... David Brigati M.D., Department of Pathology, University ... is recommended for all the rinsing steps ...
...
Biology Products: